Atlas Trials

Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

Clinical trial NCT01232881 · TERMINATED

Trial details

NCT number
NCT01232881
Sponsor
Hoosier Cancer Research Network
Status
TERMINATED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2009-08-01
Primary completion
2010-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.